Found: 4
Select item for more details and to access through your institution.
Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 5, p. 483, doi. 10.1007/s10637-008-9131-6
- By:
- Publication type:
- Article
Intermittent Oral Coadministration of a Gamma Secretase Inhibitor with Dexamethasone Mitigates Intestinal Goblet Cell Hyperplasia in Rats.
- Published in:
- Toxicologic Pathology, 2014, v. 42, n. 2, p. 422, doi. 10.1177/0192623313486315
- By:
- Publication type:
- Article
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 4, p. 590, doi. 10.1111/pcmr.12228
- By:
- Publication type:
- Article
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
- Published in:
- 2016
- By:
- Publication type:
- journal article